Aptevo Therapeutics's total assets for Q2 2026 were $14.52M, a decrease of -27.05% from the previous quarter. DE:AP82 total liabilities were $8.48M for the fiscal quarter, a 2.27% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.